LifeCannMD

MAY 27, 2025

A leading researcher in cannabis medicine documented something fascinating called the “biphasic effect.” Now, with 1.5mg of a balanced THC:CBD tincture twice daily, he’s giving presentations at work and actually enjoying social events again. Traditional medications left him feeling like a zombie.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

JANUARY 6, 2022

“I have watched how Flora, in a short time, has emerged as a leader in building a diversified global cannabis company, from its low-cost manufacturing to the clinical studies from its Flora Pharma division to its premium brand portfolio. This document contains forward-looking statements. Forward-looking statements are only predictions.

Research and Development 52

Research and Development Events Clinical Trials Business 52

Cannabis Law Report

FEBRUARY 2, 2022

– Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA). Dr. Manalo-Morgan has spent the last 5 years researching cannabis and has specialized in the formulation of cannabinoid products for clinical trials.

Cannabinoids 40

Cannabinoids Clinical Trials Events Cultivation 40

Cannabis Law Report

MARCH 29, 2020

At an HIV Community Cannabis Education event held in Toronto, a cannabis company proudly declared their company had not had a single product recall to date. This post explores the manufacturing and research standards to consider when conducting research studies with cannabis. . . Product Quality in Manufacturing.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

SEPTEMBER 8, 2021

EPN’s facility is capable of product development, manufacturing, and commercialization of cannabis consumer packaged goods in addition to the manufacture of products and formulations for use in clinical trials to a TGA and EU GMP standard. The Epsilon-Valens Management/Operational Consultancy. the “Operational Agreement”); and.

Access 97

Access Research and Development Medicine THC 97

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Adverse events reported for these participants were mild and included fatigue, diarrhea, and nausea. .

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. In conclusion, cannabidiol is associated with clinical improvement in Dravet syndrome. 1.69, 95% CI [1.20–2.36]) 1), 95%CI [??1.39–(??0.60)])

Safety 52

Safety Cannabinoids Events Data 52

TheAnswerPage

JANUARY 11, 2022

The inability of most clinicians to safely and effectively treat medical marijuana patients is well documented in the medical literature. Results of an observational study merely suggest an association between a therapeutic agent or an event and an outcome.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

DECEMBER 28, 2021

Upon completion of all the required IND enabling studies and subsequent review by the FDA, Virpax intends to conduct a Phase 1 study to evaluate the relative bioavailability and pharmacokinetics of Epoladerm™ Virpax recently announced the execution of a clinical trial agreement with Altasciences Company, Inc., Christopher M.

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

SEPTEMBER 20, 2021

If animal studies are successfully completed, Virpax plans to immediately proceed with preparing a pre-Investigational New Drug Application briefing document for the U.S. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Betsy Brod.

Epilepsy 40

Epilepsy Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K.

Therapy 40

Therapy Research and Development Business Access 40

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Adverse events reported for these participants were mild and included fatigue, diarrhea, and nausea. [7].

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JULY 15, 2022

Media event date: 27 August 2019. So without going on to the advertising side of things, very important to have your clinical trials obviously based on products. Most important to have your clinical trials based on the genetics of your plants. The Hon Greg Hunt MP. Former Minister for Health and Aged Care.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. She was Founder and Executive Producer of the award-winning future-shaping events series, Creative Innovation Global.

Medicine 52

Medicine Therapy Research and Development Business 52

Cannabis Law Report

NOVEMBER 24, 2021

Since ancient times, the use of medicinal cannabis has been documented for a wide range of ailments in regions like India, China, Tibet, and Mesopotamia, for conditions such as epilepsy, dysmenorrhea and labour pain, rheumatism, urinary tract infections, gonorrhoea, and even leprosy. 23), followed by adverse events ( n ?=?15)

Research and Development 52

Research and Development Medicine Access Media 52

CannaMD

MARCH 8, 2020

Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease. a heart attack). More research is needed.

Patients 104

Patients Marijuana Research and Development Clinical Trials 104

Cannabis Law Report

FEBRUARY 10, 2022

Despite Petitioners’ noble cause, the case turned on a technicality after the Court determined that the DEA’s letter stating that such psilocybin treatment was not allowed, the document that prompted the lawsuit, was not a “final” decision of the Attorney General that the Court had jurisdiction to review. Background. Psilocybin. The RTT Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Veriheal

JUNE 7, 2021

MDMA has also reportedly been used with over 1,000 individuals in clinical trials , with no adverse effects to report. . According to the study by Stephen Peroutka , the recreational use of MDMA in America has “never been documented adequately”. Consuming Therapeutically and Recreationally.

Therapy 92

Therapy Treatment Conditions Clinical Trials 92

The Cannigma

DECEMBER 12, 2022

He documented his “trip” while riding his bicycle home; now psychedelic enthusiasts celebrate Bicycle Day each year on April 19th. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. As such, there have been numerous clinical trials using ketamine. This stage lasts for 8 to 20 hours.

History 141

History Microdosing Research and Development Clinical Trials 141

Cannabis Law Report

JULY 14, 2021

ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. Forward-looking statements are statements that relate to future, not past, events. Karl Kottmeier” President. Investors are cautioned against attributing undue certainty to forward-looking statements.

Research and Development 81

Research and Development Clinical Trials Events Treatment 81

Cannabis Law Report

DECEMBER 30, 2019

As documented in this report, legislators across the country approved a litany of new marijuana legislation this year addressing a wide spectrum of issues. State lawmakers passed Assembly Bill 420 , which authorizes the University of California’s Center for Medicinal Cannabis Research to cultivate cannabis for clinical trials.

Legislation 45

Legislation Patients Access Banking 45

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

NORML

SEPTEMBER 20, 2019

But at the Vegas event, she brought good news: She announced that other universities would host her research, and she recently applied for a third-party cultivation license from the DEA, the only federal agency that can legally provide cannabis for clinical study in the US. That’s what made it unlawful.

DEA 229

DEA Research and Development Clinical Trials Patients 229

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. in/rickdoblin/ [link]. Julie Holland is an American psychopharmacologist, psychiatrist, and author. in/julie-holland-b1a7a13/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51